Airsculpt Technologies Inc (AIRS) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Airsculpt Technologies Inc $0.40, price $2.16, upside -81.5%, quality 37 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Structural break:
The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.
Weakest SetupStrongly overvalued and low quality.
!Fair value $0.4000 · Strongly overvalued (−81%)
!Quality 37/100
!Weak Growth(revenue 5y +19.3 %/yr)
!Loss-making · -7.4% net margin (TTM)
✓Moderate debt · generates free cash flow
!Trails peers(0/12)
!Narrow moat11/100
!Evidence only low, so the estimate is less certain
Watch Airsculpt Technologies Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
59‑month range $1.58 – $17.24 · fair‑value band $0.2200 – $0.8000 · the $2.16 price screens above the $0.4000 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Airsculpt Technologies in your weekly email
Every Wednesday you see whether Airsculpt Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada.
Show more
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
Stock analysis
Airsculpt Technologies Inc (AIRS) currently trades at $2.16, while our model-based Fair Value estimate is $0.4000, implying the stock looks roughly 440.0% overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $0.9800 per share, and 0 of the 6 models we run sit above the $2.16 price.
Bear case: the Growth DCF group reads lowest at $0.3600, and 6 of the 6 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.2200 (bear) to $0.8000 (bull), the price of $2.16 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Airsculpt Technologies Inc reported revenue of $152M in FY2025 versus $133M in FY2021, a compound +3.3%/yr. Reported net income was −$11.7M in FY2025.
Key figures
Market cap $362M · P/S ratio 2.39 · EPS (TTM) $−0.1700 · Net margin −7.7% · Return on equity −12.6% · Return on assets (EBIT) 1.4% · Operating margin −4.6% · Revenue (TTM) $152M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 81% below its 52-week high and 37% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −81%, AIRS screens richer than that median.
Fair Value models
Bear $0.2200Fair Value $0.4000Bull $0.8000
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−15.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.3%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.3%
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
16.0% (2020) → −3.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+76.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +72.0% a year for the price.
News mood ⓘNews mood, the average tone of recent news (95 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Negative
Recent news coverage is more negative than average.
Compare Airsculpt Technologies Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 258 stocks
Beats the industry median on 0/10 measures
Overall it trails its industry peers.
Valuation
Quality Score37 · Bottom 25%
Fair Value upside−82% · Bottom 25%
Profitability
Return on assets−2% · Bottom 25%
Net margin (TTM)−7% · Bottom 25%
Operating margin (TTM)−5% · Bottom 25%
Growth and dividend
Revenue growth0% · Below median
Balance sheet
Debt / equity0.58× · Highest 25%
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/B4.13× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM)2.39× · Priciest 25%
P/FCF523.5× · Priciest 25%
EV/EBITDA53.8× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)0· sector 28
PAST (return on equity)0· sector 31
HEALTH (low debt)71· sector 89
DIVIDEND (yield)0· sector 43
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Airsculpt Technologies Inc (AIRS) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.4000 versus a price of $2.16, about −81% upside (overvalued).
What is the fair value of AIRS?
Our model-based fair value for Airsculpt Technologies Inc is $0.4000 (as of Sep 23, 2026), built from audited fundamentals. The current price: $2.16.
What is the quality score of AIRS?
Airsculpt Technologies Inc has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Airsculpt Technologies Inc (AIRS)?
Our model-based price target is the fair value of $0.4000 (as of Sep 23, 2026) from 7 valuation models. Cautious scenario $0.2200, optimistic scenario $0.8000. It is a calculation from audited fundamentals, not an analyst target.
What is the Airsculpt Technologies Inc stock forecast for 2026?
Our models put fair value at $0.4000, about −81% upside versus a price of $2.16 (overvalued). Cautious scenario $0.2200, optimistic scenario $0.8000. The calculation is refreshed regularly with new filings.
What is the revenue of Airsculpt Technologies Inc (AIRS)?
Airsculpt Technologies Inc reported trailing-twelve-month revenue of about $152M (latest available figure, as of Sep 23, 2026).
What growth is priced into Airsculpt Technologies Inc (AIRS)?
For today's price to be fair in a discounted-cash-flow model, Airsculpt Technologies Inc would have to grow free cash flow by +76.1 % per year for five years (discount rate 13.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +19.3 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of AIRS use?
Our models discount Airsculpt Technologies Inc at 13.7 %: a base by market capitalisation (small), damped by beta 2.34, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Airsculpt Technologies Inc that is +76.1 % per year a year over ten years, using the same discount rate (13.7 %) and the same formula as our fair value.
How much growth has Airsculpt Technologies Inc (AIRS) delivered so far?
Over the past 5 years revenue at Airsculpt Technologies Inc grew +19.3 % a year. The price currently implies +76.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Airsculpt Technologies Inc (AIRS) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Airsculpt Technologies Inc (+76.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Airsculpt Technologies Inc (AIRS)?
The free-cash-flow yield on the price is 0.53 %: that much free cash flow Airsculpt Technologies Inc produces per unit of market value. When it exceeds the discount rate of our models (13.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Airsculpt Technologies Inc (AIRS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Airsculpt Technologies Inc it is $0.4000 per share (as of Sep 23, 2026), against a price of $2.16. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Airsculpt Technologies Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, AIRS trades above its calculated fair value: price $2.16, fair value $0.4000, a gap of about −81% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AIRS?
No. The price is what the market pays today ($2.16); the fair value is what the company's own numbers justify ($0.4000). For Airsculpt Technologies Inc the two are $1.76 per share apart. That gap is exactly why we show both numbers side by side.
How much is Airsculpt Technologies Inc worth?
The market values Airsculpt Technologies Inc at about $362M (market capitalisation, as of Sep 23, 2026). Per share that is $2.16; our models calculate a fair value of $0.4000 per share.
What do the bullish and bearish scenarios say about AIRS?
Our models span a range for Airsculpt Technologies Inc: cautious scenario $0.2200, base $0.4000, optimistic $0.8000 per share (as of Sep 23, 2026, price $2.16). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Airsculpt Technologies Inc (AIRS)?
Balance-sheet figures for Airsculpt Technologies Inc (as of Sep 23, 2026): return on equity −12.6%, debt of 0.58 per unit of equity. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is AIRS from its 52-week high?
Airsculpt Technologies Inc trades at $2.16, about 81% below its 52-week high of $11.65 and 37% above the low of $1.58 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $0.4000 is for.
Which stocks are comparable to Airsculpt Technologies Inc?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Airsculpt Technologies Inc stock attractive at the current price?
The data as of Sep 23, 2026: price $2.16, calculated fair value $0.4000 (−81%), Quality Score 37/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AIRS calculated?
We run Airsculpt Technologies Inc through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.4000, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Airsculpt Technologies Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Airsculpt Technologies Inc (AIRS)?
The closing price on Sep 23, 2026 was $2.16. Our model-based fair value is $0.4000, about −81% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Airsculpt Technologies Inc right now?
The price sits above even our optimistic bull case ($0.8000). The favourable scenario is already priced in. Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide ($0.2200 to $0.8000). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Airsculpt Technologies Inc
How large is the market capitalisation of Airsculpt Technologies Inc (AIRS)?
The market capitalisation of Airsculpt Technologies Inc is $362M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Airsculpt Technologies Inc (AIRS)?
The price-to-sales ratio of Airsculpt Technologies Inc is 2.39 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Airsculpt Technologies Inc (AIRS)?
Earnings per share at Airsculpt Technologies Inc are $−0.1700. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Airsculpt Technologies Inc (AIRS)?
The net margin of Airsculpt Technologies Inc is −7.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Airsculpt Technologies Inc (AIRS)?
The return on equity (ROE) of Airsculpt Technologies Inc is −12.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Airsculpt Technologies Inc (AIRS)?
On an EBIT basis the return on assets of Airsculpt Technologies Inc is 1.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Airsculpt Technologies Inc (AIRS)?
The operating margin of Airsculpt Technologies Inc is −4.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast are earnings growing at Airsculpt Technologies Inc (AIRS)?
Earnings per share at Airsculpt Technologies Inc are growing +200% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Airsculpt Technologies Inc (AIRS) carry?
The net debt of Airsculpt Technologies Inc is $75.1M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Airsculpt Technologies Inc in the live analysis
One click puts Airsculpt Technologies Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 23, 2026